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EFFECT OF POLYSORBATE 85 ON HUMAN SKIN 
MICHAEL MEZEI, PH.D. 
College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada 
Ten percent polysorbate 8.5, a nonionic surfactant, was applied on the upper arm of 15 
healthy individuals under occlusive dressing daily for 4 days. The other arm was similarly 
treated with the ointment base (white petrolatum USP) to provide the control area. At the 
end of treatment, macroscopic observations indicated minor erythema in 11 cases and no 
visible changes were noted on the surfactant-treated areas of 4 persons or any of the control 
areas. No definite histologic changes were observed by microscopic evaluations. The results 
of biochemical assays, however, were more definitive. The content of the epidermal 
phospholipids was elevated within a range of 5 to 65o/c as a result of the treatment with 
polysorbate 85 preparation. Radioactive tracer studies indicated higher rates of "P 
incorporation into epidermal phospholipids, TCA-soluble. DNA and R~A fractions of the 
surfactant-treated skin. Results resemble those that were documented in earlier studies with 
rabbit skin. 
The increase in cases of hand dermatitis or 
eczema in females has often been associated with 
the increased use of surface active agents present 
in household cleaners and detergents. The results 
of our previous studies with animal experiments 
[1-5] indicated that surfactants which are usually 
present in cosmetic and dermatologic preparations 
have a distinct potential to irritate the rabbit skin 
and cause histologic and biochemical changes. 
Most of these histologic and biochemical changes 
can be observed in human skin in cases of psoria-
sis, eczema, and various dermatoses [6-11]. The 
present study was undertaken to evaluate the 
effect of a selected non ionic surfactant, polysor-
bate 85%*, on human skin. 
MATERIALS A:-JD METHODS 
Fifteen healthy university students, 9 male and 6 
female, 20 to 32 years of age (mean 231. took part in the 
study. All had normal skin and no previous history of skin 
diseases. 
Approximately 0.3 gm of ointment containing lOo/c 
polysorbate 85 in white petrolatum USP was applied 
daily. for 4 days. on the upper arm under occlusive 
dressing. The other arm. serving as control, was similarly 
treated with the ointment base only (white petrolatum 
USP). Macroscopic observations were carried out each 
day before the ointment was reapplied. At the end of the 
4·day treatment the test areas were washed with cotton 
soaked in ether for 5 sec to remove substances applied 
and also surface lipids. 
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Skih samples (approximately 30-50 mg) for histologic 
and biochemical tests were taken with a Castroviejc 
keratotome [12]set to cut a0.1-mm slice. A small portion 
of each biopsy specimen was placed in a lOo/c formol-sa-
line solution and kept there until routine histologic slides 
were prepared. stained with hematoxylin and eosin, and 
examined microscopically. The remaining portion of the 
skin sample I approximately 25~45 mg) was immediately 
incubated at 3(DC in 50-ml beakers in a metabolic 
shaking incubator for 30 min. The procedures for incuba-
tion, homogenization. and isolation of various fractions 
as well as for the analytical assays have been described 
previously [3 ). 
RESL'LTS 
Macroscopic observations. The surfactant prep-
aration. after 4 days of treatment. produced only 
minor ervthema in 11 cases and no distinct, visible 
changes 'were observed on the surfactant-treated 
areas of 4 persons or any of the control areas, which 
were treated with the ointment base (white pe-
trolatum USP). 
Microscopic evaluation. 1'-io definite histologic 
differences could be observed bet ween the control 
and surfactant-treated skin specimens by micro-
scopic examination. 
Biochemical assays. Table I illustrates the data 
related to the total phospholipid content of the 
control and surfactant-treated skin. The D~A 
content is used as reference standard in order to 
reduce variations in the results, which might be 
due to factors other than biologic variations and 
individual differences in response to the treatment 
with polysorbate 85. There is still some spread in 
the data. but the effect of the surfactant treatment 
is rather obvious: the phospholipid content (ex-
pressed as lipid phosphorus) is elevated in all 
samples, with an average increase of 32%. 
The radiotracer studies indicated an increase in 
the "P incorporation in all fractions, i.e .. phospho-
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TABLE I. Phospholipid content of control and 
surfactant-treated human skin 
Phospholipid content measured as lipid phosphorus 
present in each sample in terms of DNA content of the 
same sample 
Subject no. 
l 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Mean 
SEM 
meg lipid-P/!00 meg DNA 
Surfactant-Control treated 
9.2 13.2 
9.9 13.6 
7.2 9.5 
8.4 13.6 
10.4 12.4 
8.8 13.5 
11.4 14.6 
7.3 8.8 
8.7 10.1 
8.0 13.2 
9.2 9.6 
13.1 16.8 
12.2 13.3 
10.1 11.9 
10.9 16.1 
Percent of control 
143 
138 
132 
161 
119 
153 
128 
120 
116 
165 
105 
128 
109 
118 
147 
132.13 
± 4.78 
(t ~ 7.159; p < 0.001) 
lipids (Tab. II), TCA-soluble fraction (Tab. III), 
DNA (Tab. IV), and RNA (Tab. V). The rate of "P 
incorporation into phospholipids and TCA-soluble 
fractions is always higher in the skin samples 
treated with polysorbate 85 than in the control 
samples; the average percent increase in the rate of 
"P incorporation into epidermal phospholipids 
and TeA-soluble fraction is 60% (Tab. II) and 94% 
(Tab. llll, respectively. 
With the exception of two cases (subjects num-
bers 9 and 13), the rate of incorporation of "Pinto 
DNA is always greater in surfactant-treated sam-
ples than in control samples. The average increase 
here is 32% (Tab. IV). There is only one case 
(subject number 15) where the rate of incorpora-
tion of "P into RNA is smaller in the surfactant· 
treated skin than in the ointment base·treated one 
(Tab. V). The calculated average increase is 111%. 
Statistical analysis of results indicated signifi-
cant difference between the biochemical data of 
the surfactant-treated and control samples. The p 
values were obtained from the t-test; the t was 
calculated for dependent pair data according to the 
following formula: 
t ~ x-:Y 
S.' + S) -2rS,Sy 
n 
where: X = "'.X/n; Y ~. !,Y/n; S, = standard 
deviation of control data; Sy = standard deviation 
of treated data; r ~ correlation coefficient. 
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DISCUSSION 
The above results indicate that the topical 
application of 10% polysorbate 85 produced 
smaller morphologic changes in human skin than 
those that were observed previouly in rabbit skin 
TABLE II. The rate of "P incorporation into epidermal 
phospholipids (30-m in incubation) expressed as specific 
activity: counts per min per 100 meg lipid phosphorus 
present in the tested samples 
Subject no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Mean 
SEM 
cpm x 10'/100 meg lipid·P 
Sur-factant-Control treated 
229 363 
253 387 
148 I 259 
128 I 197 166 225 
167 346 
432 594 
101 184 
137 199 
119 170 
89 90 
85 141 
122 236 
134 228 
101 173 
(t ~ 7 .565; p < 0.001) 
Percent of control 
159 
153 
175 
154 
136 
207 
136 
182 
145 
143 
101 
166 
193 
170 
171 
159.60 
±6.72 
TABLE lll. The effect of surfactant treatment on the mte 
of"P incorporation into TCA-soluble fraction of human 
skin 
Subject no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Mean 
SEM 
Specific activity 
cpm >< !0'/100 meg TCA·P 
Control Surfactant· treated 
945 2,883 
916 3.032 
3,304 6,909 
2,760 4,680 
1,506 3,803 
3,565 5,760 
772 834 
4,398 5.095 
3,123 4,775 
2,962 4,789 
1,310 2,509 
1,837 1,960 
646 977 
1,427 3,516 
949 2,356 
(t = 6.338; p < 0.001) 
Percent of control 
305 
331 
209 
170 
252 
162 
108 
116 
153 
162 
191 
107 
151 
246 
248 
194.Q7 
±17.93 
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TABLE IV. The effect of surfactant treatment on the rate 
of incorporation of "Pinto epidermal DNA 
Subject no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Mean 
SEM 
Specific activity 
cpm x 10'/100 meg DNA-P 
Control Surfactant-treated 
- -
- -
243 326 
286 414 
350 501 
509 707 
668 921 
358 590 
93 89 
367 400 
304 326 
229 307 
168 129 
215 365 
71 157 
(t ~ 4.216; p < 0.01) 
Percent of control 
-
-
135 
145 
143 
139 
138 
165 
96 
109 
107 
134 
76 
170 
222 
136.85 
± 10.22 
[1]. Macroscopically only minor erythema was 
observed in approximately two-thirds of the sub· 
jects, and no visible histologic changes were noted 
by microscopic evaluation. It seems from these 
results that rabbit skin is more sensitive to the 
surfactant tested than human skin. 
The results of biochemical assavs. however, 
resemble those that were documented with rabbit 
skin [2. 3, 5]. We stated in our previous reports [1. 
5] that short duration of treatment may result in 
minor morphologic changes, but biochemical as-
says can provide distinct differences between con-
trol and surfactant-treated skin samples at the 
early stages of the irritation. The obtained bio-
chemical data clearly indicate that cellular. meta-
bolic disturbances exist before clinical or histologic 
signs of injury. caused by the surfactant treatment. 
can be detected. 
The content of epidermal phospholipids was 
increased within the range of 5 to 65S as a result of 
the treatment with polysorbate 85 preparation 
(Tab. l); with rabbit skin a similar magnitude of 
increase (26-53%) was noted [2]. The data related 
to the "P incorporation into phospholipids (Tab. 
II) indicate that not only the content but also the 
rate of biosynthesis of phospholipids is greater in 
the surfactant-treated human skin than in the 
control sample. 
In our earlier study [1] we postulated that the 
primary site of action of surfactants is in the 
biologic membranes. Subsequent reports [2-5] and 
also the present study confirm this postulation. 
Phospholipids are major components of biologic 
membranes; a change in the content as well as in 
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the rate of biosynthesis of these lipids may be an 
indication that the membranes are affected by 
surfactants. Possible mechanisms of this surfac-
tant-membrane interaction were discussed previ-
oUBly [2,5]. There are a number of recent reports 
dealing with the surfactant-induced permeability 
changes in membranes [13-16]. 
Data presented in Tables III-V are further 
evidence that the surfactant treatment caused 
metabolic disturbances. The higher rate of "P 
incorporation into TCA-soluble, DNA and RNA 
fractions of the surfactant-treated samples indi-
cates that nucleic acids and their precursors are 
synthesized at a higher rate in the treated than in 
the control human skin. This may mean that the 
surfactant caused a more general reaction than 
damage to membranes, even though this may not 
be apparent by morphologic evaluation. A possible 
explanation of this phenomenon was presented 
previously [5]. 
Surfactants present in ointments, creams, or 
lotions may exert more harmful effects on the skin 
than surfactants present in detergents and 
household cleansing products, because of the dura-
tion of contact between skin and surfactant. The 
detergents are rinsed off with water, while cosmetic 
and dermatologic preparations are applied regu-
larly and not removed from the skin; the exposure 
of skin to these types of surfactants is more 
prolonged; therefore, surfactants in ointments. 
creams, and lotions might play a greater role in 
producing skin disorders than (as it was previously 
believed) those in detergents and household 
cleansers. 
TABLE V. The effect of surfactant-treatment on the rate 
of incorporation of "Pinto epidermal RNA 
Specific activity 
cpm , 10'/100 meg RNA-P 
Subject no Percent of control 
Control Surfactant-treated 
1 - - -
2 - -
-
3 733 1,545 211 
4 310 822 265 
5 I 357 1,159 
I 
324 
6 383 582 152 
7 350 960 I 274 
8 284 296 I 104 
9 632 2.664 421 
10 528 1,228 252 
11 578 1.449 251 
12 253 274 108 
13 393 593 151 
14 389 594 153 
15 815 743 91 
Mean 210.54 
SEM ±26.88 
(t ~ 3.415; p < 0.01) 
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Polysorbate 85 and similar nonionic surfactants 
are usually present in cosmetic and dermatologic 
preparations in concentrations varying from 1 to 
15%. They are believed to be physiologically inert 
substances, which assumption might be due to 
inadequate safety test procedures. The ·'patch 
test'' is the most frequently used screening proce-
dure in toxicity studies. The duration of patch 
tests (24-72 hr I may be too short to induce the 
visible morphologic changes by which patch tests 
are routinely evaluated. In this study no mor-
phologic, but definite biochemical, changes were 
demonstrated after 4 days of treatment. The conse-
quences of the biochemical changes were not 
determined; however, they are similar to the 
changes which have been reported in various skin 
disorders [6-11 ]. 
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